Comparative Study Between 2% Minoxidil Topical Spray vs. Intradermal Injection (Mesotherapy) for Treatment of Androgenetic Alopecia in Female Patients: A Controlled, 4-month Randomized Trial
January 2010
TLDR Mesotherapy is more effective than topical spray for female hair loss treatment.
In a 4-month randomized trial with 60 female patients suffering from androgenetic alopecia, the study compared the efficacy of 2% minoxidil topical spray against intradermal injection (mesotherapy). The results indicated that while both treatments led to hair growth improvements, mesotherapy was significantly more effective. This was determined through self-evaluation and trichogram parameters, including anagen, telogen, and vellus hair percentages. The study proposed that the enhanced effectiveness of mesotherapy could be due to the direct delivery of minoxidil to hair follicles and the stimulation of growth factors from the microtrauma caused by the mesogun. The conclusion was that minoxidil via mesotherapy is a more effective treatment for androgenetic alopecia in women than the topical application, warranting further investigation into its mechanisms.
View this study on edoj.org.eg →
Cited in this study
research Quantification of female pattern hair loss: a study in a Turkish population.
Turkish women with female pattern hair loss have lower hair density, and visual counting is more effective than digital image analysis for detecting this.
research Association of androgenetic alopecia and hypertension.
research The presence of insulin resistance and comparison of various insulin sensivity indices in women with androgenetic alopecia.
Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.
research A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
1% topical minoxidil solution significantly improved hair growth in Japanese women with androgenetic alopecia, with no major side effects.
research Effective treatment of female androgenic alopecia with dutasteride.
Dutasteride successfully treated a woman's hair loss when other treatments failed.
research Approach to the adult female patient with diffuse nonscarring alopecia
The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.
research Possible mechanisms of miniaturization during androgenetic alopecia or pattern hair loss
Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.
research Female pattern hair loss
Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.
research Current understanding of androgenetic alopecia. Part II: clinical aspects and treatment.
research The risk of coronary heart disease in men with androgenetic alopecia
Bald men may have higher heart disease risk.
research The midline part: An important physical clue to the clinical diagnosis of androgenetic alopecia in women
"Christmas tree" pattern helps diagnose female hair loss.
research Topical minoxidil in androgenetic alopecia, how good is it ?
research Androgenetic alopecia and hair growth promotion state of the art: Present and future
Current research explores hair growth drugs, while future research aims for personalized treatments.
Related
research Comparative study of efficacy of topical minoxidil versus topical minoxidil with finasteride in androgenetic alopecia
research Comparative study of efficacy of minoxidil versus minoxidil with platelet rich plasma versus minoxidil with dermaroller in androgenetic alopecia
research Effectiveness of Topical Minoxidil (5%) Plus Topical Finasteride (0.1%) Fixed-Dose Combination Versus Topical Minoxidil (5%) Plus Oral Finasteride (1 Mg/Day) in Grade II-IV Androgenetic Alopecia: A Randomized, Double Blind Clinical Trial
research Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo‐controlled trial
Injections with 0.5% minoxidil effectively treat female hair loss, increasing hair density and thickness.
research Randomized trial of electrodynamic microneedle combined with 5% minoxidil topical solution for the treatment of Chinese male Androgenetic alopecia
Combining electrodynamic microneedle with 5% minoxidil improves hair growth and reduces hair loss in Chinese men.
research Excellent response to mesotherapy as adjunctive treatment in male androgenetic alopecia
Mesotherapy helps treat male hair loss effectively.
research Comparison of the efficacy of 15% Minoxidil with Low Level Laser Therapy (LLLT) in treatment of patients with Androgenetic Alopecia (AGA) – a single blind randomized clinical trial
research Comparing the Efficacy of Mesotherapy to Topical Minoxidil in the Treatment of Female Pattern Hair Loss Using Ultrasound Biomicroscopy: A Randomized Controlled Trial.
research Comparative study between mesotherapy and topical 5% minoxidil by dermoscopic evaluation for androgenic alopecia in male: A randomized controlled trial
research A randomized controlled, single-observer blinded study to determine the efficacy of topical minoxidil plus microneedling versus topical minoxidil alone in the treatment of androgenetic alopecia
research The clinical effect of JetpPeel-assisted topical minoxidil in the treatment of androgenetic alopecia: A randomized pilot study
JetPeel-assisted minoxidil improves hair density and thickness more than minoxidil alone.
research Comparative Study of Efficacy of Topical Minoxidil 5% and Combination of Topical Minoxidil 5%, Topical Azelaic Acid 1.5% and Topical Tretinoin 0.01% on the Basis of Dermoscopic Analysis in Androgenetic Alopecia
research Frontal edema due to topical application of %5 minoxidil solution following mesotherapy injections
Applying minoxidil on the scalp after mesotherapy injections caused temporary swelling.
research Comparing the Effectiveness of Local Solution of Minoxidil and Caffeine 2.5% with Local Solution of Minoxidil 2.5% in Treatment of Androgenetic Alopecia
Minoxidil with caffeine works better for hair loss than minoxidil alone.
research An open label, multi-center clinical trial of topical 5% minoxidil solution for the treatment of male androgenetic alopecia (a phase IV study)
research A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss
5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.
research A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men
5% minoxidil works better for hair growth and density, with minor irritation.
research Androgenetic Alopecia Treated With Topical Minoxidil
Using minoxidil on balding men's scalps can increase hair growth, according to a 12-month study.
research Dose-response study of topical minoxidil in male pattern baldness
Lowest effective minoxidil concentration is 1%, but 2% works better for male pattern baldness.
research Topical Minoxidil Dose-Response Effect in Alopecia Areata
Higher minoxidil concentration (5%) works better for severe hair loss, with most patients seeing regrowth in 48-60 weeks.